The mechanism of action of nitric oxide-donating aspirin
- 1 July 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 358 (4) , 1096-1101
- https://doi.org/10.1016/j.bbrc.2007.05.038
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasiaCurrent Opinion in Gastroenterology, 2007
- Nitric Oxide–Donating Aspirin Prevents Pancreatic Cancer in a Hamster Tumor ModelCancer Research, 2006
- Positional Isomerism Markedly Affects the Growth Inhibition of Colon Cancer Cells by Nitric Oxide-Donating Aspirin in Vitro and in VivoThe Journal of Pharmacology and Experimental Therapeutics, 2005
- In Vitro Metabolism of Nitric Oxide-Donating Aspirin: The Effect of Positional IsomerismThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Nitric-oxide-donating NSAIDs as agents for cancer preventionTrends in Molecular Medicine, 2004
- Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the ratLife Sciences, 2004
- NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) miceBiochemical and Biophysical Research Communications, 2003
- Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent EffectThe Journal of Pharmacology and Experimental Therapeutics, 2002
- NO-aspirins: a class of new anti-inflammatory and antithrombotic agentsTrends in Pharmacological Sciences, 1999
- Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)Journal of Medicinal Chemistry, 1997